StratifAI is a precision oncology company developing the next generation of AI-based biomarkers to advance cancer diagnostics. It leverages its multimodal AI discovery platform, Polaris™, to identify prognostic and predictive biomarkers from clinical data and assess metastatic risk.
- Category
- Precision Oncology
- Stage
- Seed
- HQ
- Berlin, Germany
- Founded
- 2022
- Funding
- $14M